The tumor-suppressing role of EYA2 in HCC is unexpected because the previous experiments indicated a positive role of EYA2 in regulation of pro-metastatic characteristics of breast cells through the TGF-β pathway by working in concert with SIX1 protein [6]. Here, TGFB1 is linked to hepatocellular carcinoma.